WallStreetZenWallStreetZen

NASDAQ: INDV
Indivior Pharmaceuticals Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Indivior Pharmaceuticals revenue was $1.33B for the trailing 12 months ending Jun 30, 2026, with 238.8% growth year over year. Quarterly revenue for the quarter (Q2 2026) ending on Jun 30, 2026 was $343.0M, up 8.2% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, INDV annual revenue was $1.2B, with 4.3% growth year-over-year.

INDV past revenue growth

How has INDV's revenue growth performed historically?

Company
13.46%
Industry
54.43%
Market
35.43%
INDV's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
INDV's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
INDV's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

INDV revenue history

Current Revenue
$1.3B
Current Earnings
$355.0M
Current Profit Margin
26.7%

Be the first to know when INDV announces revenue.

INDV Revenue History By Year

INDV Yearly RevenueINDV RevenueINDV ChangeINDV Revenue Growth
2025-12-31$1.24B$51.00M+4.29%
2024-12-31$1.19B$95.00M+8.69%
2023-12-31$1.09B$192.00M+21.31%
2022-12-31$901.00M$110.00M+13.91%
2021-12-31$791.00M$144.00M+22.26%
2020-12-31$647.00MN/AN/A
2015-12-31$1.01B-$101.00M-9.06%
2014-12-31$1.12B-$101.00M-8.31%
2013-12-31$1.22BN/AN/A

1 of 1

Indivior Pharmaceuticals Revenue FAQ

What was INDV's revenue last quarter?

On Aug 4, 2026, Indivior Pharmaceuticals (NASDAQ: INDV) reported Q2 2026 revenue of $343.00 million up 13.58% year over year. In the same quarter last year, Indivior Pharmaceuticals's revenue was $302.00 million.

What was Indivior Pharmaceuticals's revenue in 2025?

Indivior Pharmaceuticals's annual revenue for the twelve months ending Dec 31, 2025 was $1.24 billion, a 4.29% increase year over year.

How much does Indivior Pharmaceuticals make in a day?

Based on Indivior Pharmaceuticals annual revenue for the past five years, INDV makes an average of $2,855,890.41 per day.

What was Indivior Pharmaceuticals's annual revenue growth in the past year?

As of Q3 2026, Indivior Pharmaceuticals's revenue has grown 13.46% year over year. This is 40.97 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 54.43%. Indivior Pharmaceuticals's revenue in the past year totaled $1.33 billion.

How much does Indivior Pharmaceuticals make in a year?

Indivior Pharmaceuticals's revenue by year for the past five years is:
  • Indivior Pharmaceuticals's revenue for the twelve months ending Dec 31, 2025 was $1.24 billion, a 4.29% increase year over year.
  • Indivior Pharmaceuticals's annual revenue for Dec 31, 2024 was $1.19 billion, a 8.69% increase from 2023.
  • Indivior Pharmaceuticals's annual revenue for 2023 was $1.09 billion, a 21.31% increase from 2022.
  • Indivior Pharmaceuticals's annual revenue for 2022 was $901.00 million, a 13.91% increase from 2021.
  • Indivior Pharmaceuticals's annual revenue for 2021 was $791.00 million, a 22.26% increase from 2020.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.